Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children

NCT07509047 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

390

Enrollment

OTHER

Sponsor class

Conditions

Cholera Vaccination

Interventions

BIOLOGICAL: OSP:rTTHc CCV 25 ㎍ with Aluminum phosphate
BIOLOGICAL: OSP:rTTHc CCV 25 ㎍ without Aluminum phosphate
BIOLOGICAL: Euvichol®-Plus
OTHER: Placebo
BIOLOGICAL: CCV with Aluminum, Euvichol®-Plus
BIOLOGICAL: CCV without Aluminum, Euvichol®-Plus

Sponsor

International Vaccine Institute

Collaborators

[object Object]
[object Object]